Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, 2-cohort Phase II GERCOR Study to Evaluate the Interest of Acupuncture on Oxaliplatin-induced Peripheral Neuropathy in Patients With Gastro-intestinal Solid Tumors Who Discontinued Oxaliplatin-based Chemotherapy (ACUPOX)

NCT05850130 is registered in ClinicalTrials.gov with GERCOR - Multidisciplinary Oncology Cooperative Group as lead sponsor.

NCT NCT05850130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05850130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, 2-cohort Phase II GERCOR Study to Evaluate the Interest of Acupuncture on Oxaliplatin-induced Peripheral Neuropathy in Patients With Gastro-intestinal Solid Tumors Who Discontinued Oxaliplatin-based Chemotherapy (ACUPOX)
Lead sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase
Not applicable
Overall status
Recruiting
Start date
November 22, 2023
Completion date
December 31, 2027
Enrollment
182 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, esophagus cancer, gastric cancer, liver cancer, pancreas cancer